|
|
|
Summary
of 1998 CPCRA Posters and Presentations
| 36th Annual Meeting, Infectious Diseases Society of America (IDSA), November 12, 1998, Denver, CO |
Vazquez JA, Sobel JD, Peng G, Schuman P, Steele-Moore L, Holloway W, Neaton J. Evolution of
vaginal Candida species recovered from HIV-infected women receiving fluconazole prophylaxis:
The emergence of Candida Glabrata? Poster.
abstract
| 12th World AIDS Conference, Geneva, Switzerland, June 28-July 3, 1998 |
Gibert C, Wheeler D, Collins G, Muurahainen N, Alston B, Madans M, et al. The effect of caloric supplements on weight in HIV-infected individuals with CD4 <200 cells/mm3 (CPCRA 038). Poster.
abstract
Raghavan SS, Collins G, Bartsch G, Elion R, Mannheimer S, Wheeler D, Gibert C. Micronutrient
intake among HIV-infected men & women participating in a CPCRA national trial during 1996-97.
Published abstract.
abstract
Raghavan SS, Grant L, Bartsch G, Thompson M, Williams B, Mateo N, El-Sadr W. Change in log10 HIV RNA & protease inhibitor use associated with weight change in HIV+ men in a CPCRA clinical
trial. Poster.
abstract
Williams SB, Collins G, Muurahainen N, Bartsch G, Gibert C, Raghavan SS, Wheeler D. Protein
intake is associated with body cell mass in weight-stable HIV+ men with CD4 <200/mm3. Poster.
abstract
Gibert C, Muurahainen N, Collins G, Williams B, Raghavan S, Bartsch G, Wheeler D. Body
composition in HIV-infected men and women in 1996-1997 (CPCRA 038). Poster.
abstract
Caldwell P, Murphy R, Chan C, Yurik T, Scott J, El-Sadr W. Atovaquone suspension (ATQ) for prophylaxis of Pneumocystis carinii pneumonia (PCP): Effects of baseline prophylaxis on safety and efficacy. Poster.
abstract
Muurahainen N. Body cell mass (BCM) in HIV-infected (HIV+) males in 1996-1997. Poster.
abstract
Chaisson R, Gordin F, Matts J, Miller C, Garcia L, Hafner R, O'Brien R. A randomized trial of rifampin/pyrazinamide for 2 months vs. INH for 12 months in HIV+, tuberculin+ adults (CPCRA 004/ACTG 177/CDC/PAHO). Oral and poster.
abstract
Brosgart C, Pulling C, Chaloner K, Fisher E, Coakley D, Diggins M, Ioannidis J, and the CPCRA 039 Team. Serum carnitine levels in AIDS patients with advanced HIV disease from the CPCRA 039 trial. Published abstract.
abstract
| 2nd International Workshop on Drug Resistance & Treatment Strategies, June 26, 1998, Italy |
Baxter JD, Mayers DL, Hoover ML, Winters MA, Weislow OS, Neaton JD, Wentworth DN, Merigan
TC, and the CPCRA 046 Study Team. Prevalence and associations of the G73S mutation in patients
failing protease inhibitor therapy in CPCRA 046. Poster.
abstract
| ACSM 45th Meeting, June 3-6, 1998 |
Myers MJ, Walker AJ, Collins G, Bartsch G, Launer C, Williams B. Muscle building activity versus physical activity questionnaire as a predictor of body composition. Poster.
abstract
| ALA/ATS International Conference, April 24-29, 1998, Chicago, IL |
El-Sadr W, Perlman D, Matts J, Nelson E, Cohn D, Salomon N, Olibrice M, Telzak E, Jones B, Hafner. Intermittent short course therapy for the treatment of HIV-related pulmonary tuberculosis: a prospective randomized trial in the US (CPCRA 019/ACTG 222). Poster.
abstract
El-Sadr W, Luskin-Hawk R, Yurik T, Pulling C, Hafner R. Daily trimethoprim-sulfamethoxazole (TMS) is preferred choice for the prevention of P. carinii pneumonia. Poster
abstract
| 5th Conference on Retroviruses and Opportunistic Infections, February 2-5, 1998 |
Mayers DL, Neaton JD, Perez G, Baxter JD, MacArthur RD, Markowitz NP, Dehlinger ME, Howard SF, Thompson MA, and the CPCRA 036 Study Team. Prior saquinavir therapy leads to a modest decrease in subsequent responses to drug regimens containing indinavir or ritonavir. Poster.
abstract
Gordin F, Chaisson R, Matts J, Miller C, Garcia L, Hafner R, O'Brien R for the CPCRA/ACTG/PAHO/CDC Study Team. A randomized trial of 2 months of rifampin (RIF) and pyrazinamide (PZA) versus 12 months of isoniazid (INH) for the prevention of tuberculosis (TB) in HIV-positive(+), PPD+ patients (pts). Poster.
abstract
Shlay J, Chaloner K, Max M, Flaws B, Reichelderfer P, Wentworth D, Brizz B, Cohn D. A randomized, placebo-controlled trial of a standardized acupuncture regimen or amitriptyline for pain caused by HIV-associated peripheral neuropathy. Poster.
abstract
Muurahainen N, Collins G, Wheeler D, Bartsch G, Gibert C. Nutritional status and intake of HIV- infected men in 1996-1997. Poster.
abstract
El-Sadr W, Yurik T, Luskin-Hawk R, Murphy R, Hafner R, Neaton J. Increased risk of P. carinii pneumonia but not death or other AIDS events among trimethoprim-sulfamethoxazole intolerant patients. Poster.
abstract
Murphy R, El-Sadr W, Cheung T, Luskin-Hawk R, Yurik T, Neaton J, Hafner R for the CPCRA 034/ACTG 277 Team. Impact of protease inhibitor containing regimens on the risk of developing opportunistic infections and mortality in the CPCRA 034/ACTG 277 study.
abstract
El-Sadr W, Yurik T, Luskin-Hawk R, Hafner R. Pattern and timing of adverse events after initiation of different doses of trimethoprim-sulfamethoxazole (TMS) prophylaxis for P. carinii pneumonia. Poster.
abstract
Brosgart C, Pulling C, Chaloner K, Fisher E, Coakley D, Verheggen R, Diggins M, Ioannidis J, and the CPCRA 039 Team. Prevalence of asymptomatic CMV retinitis in AIDS patients. Poster.
abstract
|
|
